IPO registrations (S-1, F-1) · Registrants
INSULET CORP
- SEC CIK
- 1145197 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2007-02-14, last 2007-10-29; 2 initial registrations, 5 amendments
- Outcome
- Final prospectus filed 2007-05-15; declared effective 2007-05-14
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- DE
- Business address
- 100 NAGOG PARK, Acton, MA 01720
- EIN
- 04-3523891
- Ticker
- PODD (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- INSULET CORP on the corporate pages
Offering terms
- Proposed price range
- $14.00–$16.00 per share (S-1/A filed 2007-05-11)
- Final price
- $15.00 per share, within the range (424B4 filed 2007-05-15, an initial public offering)
- Shares sold
- 7,700,000
- Gross proceeds
- $115,500,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol PODD
- Lead underwriters
- J.P. Morgan (2,695,000 shares)
- Syndicate
- Lynch & Co; Weisel Partners LLC; Swann & Company; Merrill Lynch (2,695,000); Thomas Weisel Partners (1,463,000); Leerink Partners (847,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: INSULET CORPORATION EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: INSULET CORPORATION Fuzzy (name and state)
- Business registration: INSULET CORPORATION Fuzzy (name and state)
- Business registration: INSULET CORPORATION Fuzzy (name and state)
- Form 5500 plan sponsor: INSULET CORPORATION EXACT (EIN (EXACT))
- Federal award recipient: INSULET CORPORATION Fuzzy (name and state)
- Lobbying client: INSULET CORPORATION Fuzzy (name and state)
- Lobbying client: INSULET CORPORATION Fuzzy (name and state)
- Lobbying client: INSULET CORPORATION Fuzzy (name and state)
- Lobbying client: INSULET CORPORATION Fuzzy (name and state)
- Lobbying client: INSULET CORPORATION Fuzzy (name and state)
- Lobbying client: INSULET CORPORATION Fuzzy (name and state)
- Lobbying client: INSULET CORPORATION Fuzzy (name and state)
- Lobbying client: INSULET CORPORATION Fuzzy (name and state)
- Lobbying registrant: INSULET CORPORATION Fuzzy (name and state)
- SEC filer: INSULET CORP EXACT (CIK (EXACT))
- Person page: Daniel J Levangie Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer))
- Person page: David A Howe Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer))
- Person page: David A Lemoine Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Rebecca B Robertson Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Other))
Filings 14
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2007-02-14 | S-1 | S-1 (registration) | INSULET CORP | 0000950135-07-000827 ↗ |
| 2007-04-04 | S-1/A | S-1/A (amendment) | INSULET CORP | 0000950135-07-002053 ↗ |
| 2007-04-25 | S-1/A | S-1/A (amendment) | INSULET CORP | 0000950135-07-002416 ↗ |
| 2007-05-09 | S-1/A | S-1/A (amendment) | INSULET CORP | 0000950135-07-003014 ↗ |
| 2007-05-11 | S-1/A | S-1/A (amendment) | INSULET CORP | 0000950135-07-003099 ↗ |
| 2007-05-14 | S-1MEF | S-1MEF (added securities) | INSULET CORP | 0000950135-07-003148 ↗ |
| 2007-05-14 | EFFECT | EFFECT (declared effective) | INSULET CORP | 9999999995-07-001938 ↗ |
| 2007-05-15 | 424B4 | 424B4 (final prospectus) | INSULET CORP | 0000950135-07-003161 ↗ |
| 2007-10-19 | S-1 | S-1 (registration) | INSULET CORP | 0000950135-07-006247 ↗ |
| 2007-10-29 | S-1/A | S-1/A (amendment) | INSULET CORP | 0000950135-07-006422 ↗ |
| 2007-11-06 | EFFECT | EFFECT (declared effective) | INSULET CORP | 9999999995-07-004377 ↗ |
| 2007-11-07 | 424B4 | 424B4 (final prospectus) | INSULET CORP | 0000950135-07-006767 ↗ |
| 2009-04-08 | EFFECT | EFFECT (declared effective) | INSULET CORP | 9999999995-09-000894 ↗ |
| 2009-04-08 | EFFECT | EFFECT (declared effective) | INSULET CORP | 9999999995-09-000895 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2007-05-11 | S-1/A | registration statement | $14.00–$16.00 | 6,700,000 | - | Nasdaq PODD | 7 | primary document; range, shares headline, cover names 7 | document ↗ | |
| 2007-05-15 | 424B4 | final prospectus | $15.00 | 7,700,000 | $115,500,000 | Nasdaq PODD | 7 | primary document; price sentence, shares headline, proceeds table, underwriting table 4, cover names 7 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| ATWOOD BRIAN G | Other; TenPercentOwner | 2 | 2007 | ||
| BOESS CARSTEN | Officer | Chief Financial Officer; Vice President, International | 18 | 2007–2011 | |
| Brooks John L | TenPercentOwner | 4 | 2007–2008 | ||
| COLELLA SAMUEL D | Other; TenPercentOwner | 2 | 2007 | ||
| DePietro Ruthann | Officer | Vice President of Quality | 39 | 2007–2012 | |
| DeSisto Duane | Director,Officer | President and CEO | 44 | 2007–2014 | |
| Diehl R Anthony | Officer | General Counsel; Secretary and General Counsel | 49 | 2007–2015 | |
| Eichhorn Gary | Director | 5 | 2007–2009 | ||
| Garibotto John | Officer | Vice President of Research | 4 | 2007–2009 | |
| Gvazdauskas Shawna | Officer | Senior Vice President of Sales; Vice President of Sales | 7 | 2007–2009 | |
| ISALY SAMUEL D | Director | 1 | 2007 | ||
| JAFFE ROSS A MD | Director; Director,TenPercentOwner | 9 | 2007–2012 | ||
| LIAMOS CHARLES T | Director; Director,Officer | Chief Operating Officer | 27 | 2007–2015 | |
| LINK WILLIAM J PHD | Other; TenPercentOwner | 2 | 2007 | ||
| LUBASH BARBARA N | Other; TenPercentOwner | 2 | 2007 | ||
| Malave Luis | Officer | Chief Operating Officer | 12 | 2007–2010 | |
| MILDER DONALD B | Other; TenPercentOwner | 2 | 2007 | ||
| Nye Gordon E | Director; Director,TenPercentOwner; TenPercentOwner | 4 | 2007–2008 | ||
| ORBIMED ADVISORS LLC | Director | 2 | 2007 | ||
| ORBIMED CAPITAL GP II LLC | Director | 1 | 2007 | ||
| PEQUOT CAPITAL MANAGEMENT INC | Other | 2 | 2007 | ||
| Peyromaure de Bord Alison | Director | 4 | 2007–2008 | ||
| Prism Investment Partners III LP | TenPercentOwner | 5 | 2007–2008 | ||
| PRISM VENTURE PARTNERS III A LP | TenPercentOwner | 4 | 2007–2008 | ||
| Prism Venture Partners III LLC | TenPercentOwner | 5 | 2007–2008 | ||
| PRISM VENTURE PARTNERS III LP | TenPercentOwner | 4 | 2007–2008 | ||
| ROBERTSON REBECCA B | Other; TenPercentOwner | 2 | 2007 | person page Fuzzy | |
| Schmid Kevin | Officer | Vice President Manufacturing; VP of Operations & Engineering | 6 | 2007–2009 | |
| Seifert William M | TenPercentOwner | 5 | 2007–2008 | ||
| SILVERSTEIN JONATHAN | Director | 3 | 2007 | ||
| Smith Jefferey | Officer | Vice President of Marketing | 2 | 2007–2008 | |
| SOBIESKI STEVEN | Director | 12 | 2007–2015 | ||
| VERSANT AFFILIATES FUND I-A LP | Other; TenPercentOwner | 2 | 2007 | ||
| VERSANT AFFILIATES FUND I-B LP | Other; TenPercentOwner | 2 | 2007 | ||
| VERSANT SIDE FUND I LP | Other; TenPercentOwner | 2 | 2007 | ||
| VERSANT VENTURE CAPITAL I LP | Other; TenPercentOwner | 2 | 2007 | ||
| VERSANT VENTURES I LLC | Other; TenPercentOwner | 2 | 2007 | ||
| Boesgaard Lars | Officer | Vice President of Finance | 5 | 2007–2009 | |
| Campbell Robert | Officer | Vice President for Clinical | 16 | 2007–2010 | |
| Bubrick Stephen | Officer | Vice President of Customer | 2 | 2007 | |
| Ng Jason | Officer | Vice President of Asian Operat | 3 | 2008–2009 | |
| Suchoff Andrew | Officer | Chief Human Resources Officer | 2 | 2008 | |
| SOMMER REGINA O | Director | 15 | 2008–2017 | ||
| Zakrzewski Joseph S | Director | 14 | 2008–2017 | ||
| ARTHUR WILLIAM D III | Officer | V.P. of Business Development | 3 | 2008–2009 | |
| CRAWFORD SALLY | Director | 19 | 2008–2021 | ||
| Howe David A | Officer | VP of Human Resources | 3 | 2009 | person page Fuzzy |
| ROBERTS BRIAN K | Officer | Chief Financial Officer | 23 | 2009–2014 | |
| Devlin Peter | Officer | Chief Commercial Officer | 16 | 2009–2014 | |
| LEVANGIE DANIEL J | Director; Officer | EVP & President, Drug Delivery; President, Drug Delivery | 12 | 2011–2016 | person page Fuzzy |
| LORTZ W MARK | Director | 4 | 2012–2013 | ||
| Fallon John A. | Director | 18 | 2012–2021 | ||
| Ryan Patrick | Officer | Chief Operating Officer | 5 | 2014–2015 | |
| Wielinski Tracey Haas | Officer | VP, Global Regulatory, CA, QA | 4 | 2014 | |
| Scannell Timothy J | Director | 17 | 2014–2026 | ||
| SULLIVAN PATRICK J | Director,Officer | CEO and Chairman of the Board; President & CEO | 20 | 2014–2018 | |
| Hayes Kathleen | Officer | Vice President, HR | 1 | 2014 | |
| Dorval Allison | Officer | Chief Financial Officer | 5 | 2014–2015 | |
| Thomas Bradley A | Officer | EVP Human Resources | 22 | 2014–2018 | |
| Petrovic Shacey | Director; Director,Officer; Officer | Advisor; CCO; President and CEO; President and COO; President, Diabetes Products | 69 | 2015–2024 | |
| Levitz Michael L | Officer | CFO; SVP and CFO | 12 | 2015–2019 | |
| Colleran David | Officer | Secretary and General Counsel; SVP, Secretary and GC | 16 | 2015–2019 | |
| Hopfield Jessica | Director | 17 | 2015–2026 | ||
| Alpuche Charles | Officer | Advisor; EVP & Chief Operating Officer; EVP & Chief Operations Officer; EVP, Global Manufacturing; SVP, Global Manufacturing | 40 | 2016–2023 | |
| Lemoine David A | Director | 19 | 2016–2021 | person page Fuzzy | |
| Spears Michael P | Officer | Advisor; SVP, QA and RA; SVP, QA, RA and CA; SVP, Quality and Regulatory; SVP, RA and Compliance | 47 | 2016–2023 | |
| Abdel-Malek Aiman | Officer | EVP & Chief Technology Officer; SVP, Advanced Technology | 19 | 2016–2019 | |
| Christensen Bret | Officer | EVP and CCO; SVP and CCO | 29 | 2017–2023 | |
| MINOGUE MICHAEL R | Director | 17 | 2017–2026 | ||
| MULLEN JAMES C | Director | 4 | 2017–2018 | ||
| Benjamin Eric | Officer | EVP and COO; EVP, CPXO; EVP, CPXPO; EVP, Innovation and Strategy; SVP, Innovation and Strategy; SVP, R&D, New Prod Dev & Comm; SVP, R&D, New Prod Dev. & Comm | 36 | 2018–2026 | |
| Nevinny Corinne H | Director | 9 | 2019–2023 | ||
| McMillan Wayde D. | Officer | EVP, CFO | 22 | 2019–2023 | |
| Kapples John W. | Officer | SVP and General Counsel; SVP, Secretary and GC | 25 | 2019–2026 | |
| Budden Lauren | Officer | Group VP, CAO and Controller; Interim CFO and Treasurer; VP, CAO and Controller | 27 | 2019–2026 | |
| Hollingshead James | Director; Director,Officer; Officer | Former President and CEO; President and CEO | 15 | 2019–2025 | |
| Manea Dan | Officer | SVP, Chief HR Officer | 19 | 2020–2025 | |
| Frederick Wayne A.I. | Director | 10 | 2020–2026 | ||
| BORIO LUCIANA | Director | 13 | 2021–2026 | ||
| WEATHERMAN ELIZABETH H | Director | 8 | 2022–2026 | ||
| Cousin Laetitia | Officer | SVP, Reg, Quality & Compliance | 12 | 2023–2026 | |
| Singh Prem | Officer | SVP, Global Operations | 16 | 2023–2026 | |
| Field Mark N | Officer | SVP & Chief Technology Officer | 13 | 2023–2025 | |
| Pease Flavia | Director; Officer | EVP & CFO | 6 | 2024–2026 | |
| STONESIFER TIMOTHY C. | Director | 7 | 2024–2026 | ||
| Chadwick Ana Maria | Officer | EVP, CFO & Treasurer | 5 | 2024–2025 | |
| McEvoy Ashley | Director,Officer | President and CEO | 6 | 2025–2026 | |
| Davis Lisa Blair | Officer | SVP, Chief HR Officer | 4 | 2025–2026 | |
| Huffines Robert Luther | Director | 7 | 2025–2026 | ||
| Panos Michael | Officer | EVP and CCO | 2 | 2026 | |
| MAZELSKY JONATHAN JAY | Director | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | INSULET CORPORATION | MA | State business registries | EIN (EXACT, as the state registration reports it) |
| Plan sponsor | INSULET CORPORATION | MA | Form 5500 (employee benefit plans) | EIN (EXACT) |
| SEC filer | INSULET CORP | SEC filers (EDGAR) | CIK (EXACT) | |
| Business registration | INSULET CORPORATION | State business registries | name and state | |
| Business registration | INSULET CORPORATION | State business registries | name and state | |
| Business registration | INSULET CORPORATION | State business registries | name and state | |
| Form 5500 plan sponsor | INSULET CORPORATION | EIN (EXACT) | ||
| Federal award recipient | INSULET CORPORATION | Federal spending (USAspending) | name and state | |
| Lobbying client | INSULET CORPORATION | Federal lobbying (LDA) | name and state | |
| Lobbying client | INSULET CORPORATION | Federal lobbying (LDA) | name and state | |
| Lobbying client | INSULET CORPORATION | Federal lobbying (LDA) | name and state | |
| Lobbying client | INSULET CORPORATION | Federal lobbying (LDA) | name and state | |
| Lobbying client | INSULET CORPORATION | Federal lobbying (LDA) | name and state | |
| Lobbying client | INSULET CORPORATION | Federal lobbying (LDA) | name and state | |
| Lobbying client | INSULET CORPORATION | Federal lobbying (LDA) | name and state | |
| Lobbying client | INSULET CORPORATION | Federal lobbying (LDA) | name and state | |
| Lobbying registrant | INSULET CORPORATION | Federal lobbying (LDA) | name and state | |
| Person page | Daniel J Levangie | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer) | |
| Person page | David A Howe | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer) | |
| Person page | David A Lemoine | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Rebecca B Robertson | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Other) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Surgical & Medical Instruments & Apparatus, MA first:
- NMT MEDICAL INC MA
- ARBIOS SYSTEMS INC MA
- LEMAITRE VASCULAR INC MA
- BIOVENTRIX, INC. MA
- NeuroMetrix, Inc. MA
- INVIVO THERAPEUTICS HOLDINGS CORP. MA
- ACCELLENT LLC MA
- Lyra Therapeutics, Inc. MA
- T2 Biosystems, Inc. MA
- Corindus Vascular Robotics, Inc. MA
In other datasets, the same topic (Technology) in MA:
- Form D issuer: 10 Percent Happier, Inc. (Form D private offerings)
- Lobbying client: 5G ACTION NOW (Federal lobbying (LDA))
Interests: Surgical & Medical Instruments & Apparatus · Technology